Stryker Buys Canadian Hospital Beds Firm
This article was originally published in The Gray Sheet
Executive Summary
The company says the buy will expand its portfolio to include low-height hospital beds that are safer for patients.
You may also be interested in...
Stryker Could Bid for Smith & Nephew Soon
Stryker may make bid for Smith and Nephew this week in a deal that would be completed by end of next year, according to analysts. While the deal makes strategic sense, analysts warn it could carry higher regulatory risk.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.
MoCRA’s Adulteration Ambiguity And FDA’s New Cosmetic Recall Authority: Attorney Weighs In
The US FDA should use guidance or rulemaking to clarify MoCRA provisions related to adulteration, Amin Wasserman Gurnani attorney Angela Diesch suggested at the Independent Beauty Association’s Cosmetics Convergence Spring Symposium. Attendees also sought her take on whether the agency’s new recall authority is likely to spell an increase in cosmetic product recalls.